News
Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung ...
AI scans general practitioner notes to spot lung cancer 4 months earlier, boosting survival chances with faster diagnosis and ...
New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...
2d
Pharmaceutical Technology on MSNAstraZeneca enters $200m AI cancer pact with Tempus and PathosAstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.
Artificial Intelligence can detect signs of lung cancer up to four months more quickly than family doctors, a study by ...
Prevalence of dyspnea is high among advanced cancer survivors, with several associated factors, stressing a need for early detection and comprehensive management strategies.
The following is a summary of "Prediction of radiosensitivity in non-small cell lung cancer based on computed tomography and tumor genomics: a multiple real-world cohort study," published in the April ...
A new study has identified a potential new therapy for pulmonary tuberculosis that could shorten the length of treatment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results